medlogicai.org

Clinical intelligence. Better decisions.

Decision-Making Algorithm in Otorhinolaryngology & Head and Neck Surgery

Cholesteatoma

Modern otologic decision algorithm — diagnosis, classification, surgical choice, and lifelong surveillance

Step 1

Step 1 of 17

Clinical Suspicion & History

Recurrent foul otorrhoea · hearing loss · attic crust · retraction pocket · vertigo · facial weakness

Cholesteatoma is suspected from a focused history before the ear is even examined. Six clinical clusters trigger the pathway: recurrent foul-smelling otorrhoea refractory to antibiotics, progressive conductive hearing loss, an attic crust or visible retraction pocket on prior examination, otogenic vertigo or imbalance, peripheral facial weakness, or a history of multiple ear infections in childhood.

Beyond the symptoms themselves, the history must capture modifiers that change the diagnostic and surgical plan: duration of otorrhoea, hearing-loss tempo, prior ear surgery (revision disease behaves differently), trauma or myringotomy that could have implanted epithelium, sinonasal disease and eustachian-tube symptoms, and paediatric risk factors (cleft palate, craniofacial syndromes, Down syndrome).

  • Duration and character of otorrhoea (chronic, foul, refractory)
  • Hearing-loss progression — conductive vs mixed vs sensorineural
  • Prior ear surgery (tympanoplasty, mastoidectomy, ventilation tubes)
  • Trauma / myringotomy history (implantation risk)
  • Vertigo / imbalance — fistula sign, labyrinthine erosion
  • Facial weakness — facial nerve canal erosion
  • Paediatric risk — cleft palate, Down syndrome, craniofacial anomalies
  • Sinonasal / eustachian-tube dysfunction symptoms

★ High-yield pearls (chapter-wide)

  • Six clinical clusters trigger the pathway — foul otorrhoea, hearing loss, attic crust, retraction, vertigo, facial weakness.
  • Screen for complications before any elective workup — extracranial and intracranial.
  • Otoendoscopy maps the hidden recesses microscopy cannot reach — sinus tympani, facial recess, anterior epitympanum, supratubal recess, hypotympanum, protympanum.
  • Aetiology informs behaviour — congenital, primary acquired, secondary acquired, implantation.
  • ET dysfunction is half the disease — address it explicitly, especially in paediatric and recurrent cases.
  • HRCT temporal bone is the surgical map; non-EPI DWI MRI is the modern surveillance tool; contrast MRI is for complications.
  • Limited attic / mesotympanic → endoscopic. Extensive mastoid → tympanomastoidectomy.
  • CWU vs CWD — limited disease + good ET + reliable follow-up favours CWU; extensive disease, fistula, poor ET, or poor follow-up favours CWD.
  • Labyrinthine fistula — small repair carefully; large preserve matrix and CWD.
  • Paediatric disease is more aggressive — lower threshold for staging and surveillance.
  • Stage surgery for piecemeal removal, doubtful clearance, or high adhesion risk.
  • DWI MRI has replaced obligatory second-look in confident, reliable adult cases.
  • Residual disease is surgical-technique driven; recurrent disease is ET-dysfunction driven.
  • Final goals: safe ear, dry ear, complete eradication, hearing preserved or restored, facial nerve safe, intracranial complications prevented, lifelong surveillance.

Evidence base

6 sources
  1. HIGH

    Yung M et al. · J Int Adv Otol · 2017EAONO/JOS international consensusPMID 28059056

    International expert consensus defining modern cholesteatoma terminology, classification, staging (STAM system), and reporting standards. Widely accepted framework for clinical diagnosis and disease categorisation. Expert consensus; Level V evidence. Vol 13(1):1-8.

  2. HIGH

    Olszewska E et al. · Eur Arch Otorhinolaryngol · 2004Comprehensive pathogenesis reviewPMID 12835944

    Comprehensive review synthesising the major theories of cholesteatoma pathogenesis — retraction-pocket formation, epithelial migration, basal-cell hyperplasia, inflammatory mechanisms. Foundational reference for disease evolution and clinical suspicion. Narrative review; Level V evidence. Vol 261(1):6-24.

  3. MOD

    Sadé J, Fuchs C, Luntz M · Arch Otolaryngol Head Neck Surg · 1997Sadé retraction-pocket theoryPMID 9193217

    Observational anatomical study supporting the pars flaccida retraction-pocket theory and its association with mastoid pneumatisation and eustachian-tube dysfunction in acquired cholesteatoma. Anatomical-physiological study; Level IV evidence. Vol 123(6):584-588.

  4. HIGH

    Levenson MJ, Michaels L, Parisier SC · Laryngoscope · 1988Levenson-Michaels-Parisier congenital cholesteatoma seriesPMID 3412093

    Classic clinicopathologic study describing congenital cholesteatoma presentation, retrotympanic white masses, intact tympanic membrane findings, and embryologic origin. Clinicopathologic observational study; Level IV evidence. Vol 98(9):949-955.

  5. HIGH

    Nevoux J et al. · Eur Ann Otorhinolaryngol Head Neck Dis · 2010Paediatric cholesteatoma comprehensive reviewPMID 20860924

    Comprehensive paediatric cholesteatoma review discussing aggressive clinical behaviour, delayed diagnosis, recurrence tendencies, and characteristic paediatric presentation patterns. Comprehensive review; Level V evidence. Vol 127(4):143-150.

  6. MOD
    Classification of retraction pockets in the pars tensa and pars flaccida

    Charachon R et al. · Adv Otorhinolaryngol · 1999Retraction-pocket classification

    Clinical classification study describing progression patterns of pars flaccida and pars tensa retraction pockets and their role in cholesteatoma development. Clinical observational study; Level IV evidence. Vol 55:190-193.

Step 1

Disclaimer

For educational purposes only. Not for clinical use. This platform is an instructional resource intended to support learning about clinical decision-making and the interpretation of investigations. Clinicians remain completely responsible for the interpretation of findings, the formulation of a differential diagnosis, and any clinical decision. Nothing in this application replaces individualized assessment, hands-on training, expert consultation, or established practice guidelines.

Not for profit effort by

Dr. Prahlada N.B

  • MBBS (JJMMC), MS (PGIMER, Chandigarh)
  • MBA in Hospital & Healthcare Management (BITS, Pilani)
  • Postgraduate Certificate in Technology Leadership and Innovation (MIT, USA)
  • Executive Programme in Strategic Management (IIM, Lucknow)
  • Senior Management Programme in Healthcare Management (IIM, Kozhikode)
  • Advanced Certificate in AI for Digital Health and Imaging Program (IISc, Bengaluru)

Supporting organisations

  • Karnataka ENT Hospital and Research Centre (R)
  • Champions Educational and Medical Society (R)
  • Amogh Foundation